XWELL Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $28.3M-16.6% YoYTTM through 30 Jun 2026
Net Income -$23.4MTTM through 30 Jun 2026
Free Cash Flow -$13.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 35.5% |
| EBITDA Margin | -58.3% |
| Operating Margin | -78.3% |
| Net Margin | -82.9% |
Returns
-338.6%ROE
-136.6%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.35x
Net Debt-$16.8Mnet cash position
Cash & Equivalents$11.8M
Quality Metrics
Altman Z-Score-34.86
Piotroski F-Score3 / 9
FCF Margin-47.6%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $29.2M
Diluted EPS-$5.21TTMFY2025: $-3.06
Dividend
No dividend
Capital Allocation
Capex Intensity7.8%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| XpresSpa | View detailsFocusing on expanding off-airport wellness retail locations, such as the Penn Station location. | ||
| XpresTest | View detailsExpanding global biosecurity strategy and traveler-based pathogen surveillance capabilities. | ||
| Naples Wax Center | View detailsExpanding off-airport footprint in key Florida markets. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.